Title | Type | SJR | H index | Total Docs. (2000) | Total Docs. (3years) | Total Refs. (2000) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2000) | %Female (2000) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Reading Teacher | journal | 1.014 Q1 | 60 | 64 | 177 | 1232 | 117 | 177 | 0.75 | 19.25 | 67.96 | |
52 | CNS Drug Reviews | journal | 0.282 Q3 | 64 | 23 | 96 | 1454 | 84 | 96 | 0.68 | 63.22 | 14.52 | |
53 | Drug and Chemical Toxicology | journal | 0.238 Q3 | 54 | 44 | 125 | 1220 | 84 | 124 | 0.66 | 27.73 | 30.40 | |
54 | Journal of the American Pharmacists Association : JAPhA | journal | 0.190 Q3 | 73 | 141 | 296 | 1488 | 189 | 270 | 0.66 | 10.55 | 47.66 | |
55 | Cardiovascular Drug Reviews | journal | 0.322 Q3 | 54 | 26 | 74 | 888 | 69 | 74 | 0.65 | 34.15 | 17.14 | |
56 | Journal of Pharmacological and Toxicological Methods | journal | 0.389 Q2 | 83 | 56 | 183 | 2614 | 194 | 181 | 0.65 | 46.68 | 24.40 | |
57 | Journal of Biopharmaceutical Statistics | journal | 1.190 Q1 | 56 | 38 | 132 | 618 | 107 | 127 | 0.64 | 16.26 | 18.18 | |
58 | Adverse Drug Reaction Bulletin | journal | 0.163 Q3 | 8 | 6 | 18 | 175 | 10 | 18 | 0.58 | 29.17 | 11.11 | |
59 | American Journal of Health-System Pharmacy | journal | 0.295 Q3 | 107 | 449 | 1379 | 4207 | 819 | 887 | 0.57 | 9.37 | 35.06 | |
60 | American Journal of Therapeutics | journal | 0.223 Q3 | 69 | 57 | 175 | 1682 | 98 | 160 | 0.56 | 29.51 | 21.19 | |
61 | Current Therapeutic Research | journal | 0.250 Q3 | 46 | 99 | 281 | 2478 | 171 | 248 | 0.53 | 25.03 | 27.94 | |
62 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.328 Q2 | 40 | 75 | 352 | 2504 | 275 | 352 | 0.53 | 33.39 | 22.76 | |
63 | Food and Drug Law Journal | journal | 0.279 Q3 | 23 | 41 | 151 | 4578 | 61 | 151 | 0.41 | 111.66 | 32.26 | |
64 | Journal of Herbs, Spices and Medicinal Plants | journal | 0.199 Q3 | 34 | 50 | 80 | 975 | 31 | 79 | 0.31 | 19.50 | 36.36 | |
65 | Pharmacopeial Forum (discontinued) | journal | 0.229 Q3 | 20 | 12 | 50 | 175 | 12 | 50 | 0.24 | 14.58 | 23.81 | |
66 | Journal of Infectious Disease Pharmacotherapy | journal | 0.141 Q3 | 6 | 0 | 29 | 0 | 6 | 28 | 0.21 | 0.00 | 0.00 | |
67 | Neuropsychopharmacology Reports | journal | 22 | 40 | 109 | 1182 | 25 | 108 | 0.21 | 29.55 | 8.16 | ||
68 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.120 Q4 | 29 | 0 | 24 | 0 | 4 | 22 | 0.17 | 0.00 | 0.00 | |
69 | Clinical Research and Regulatory Affairs | journal | 0.117 Q4 | 18 | 17 | 60 | 310 | 7 | 57 | 0.16 | 18.24 | 11.11 | |
70 | Hospital Pharmacy | journal | 0.139 Q4 | 28 | 167 | 472 | 2262 | 83 | 395 | 0.16 | 13.54 | 38.79 | |
71 | Proceedings of the Western Pharmacology Society | journal | 0.140 Q4 | 25 | 28 | 396 | 397 | 43 | 395 | 0.12 | 14.18 | 33.33 | |
72 | Research Communications in Pharmacology and Toxicology | journal | 0.124 Q4 | 8 | 10 | 61 | 351 | 8 | 61 | 0.05 | 35.10 | 25.00 | |
73 | Drug Topics | journal | 0.110 Q4 | 8 | 543 | 1822 | 0 | 52 | 1309 | 0.03 | 0.00 | 47.17 | |
74 | Pharmaceutical Chemistry Journal | journal | 0.100 Q4 | 39 | 174 | 489 | 2479 | 5 | 489 | 0.01 | 14.25 | 58.53 | |
75 | Advances in Drug Research | journal | 0.604 Q2 | 11 | 0 | 9 | 0 | 23 | 9 | 0.00 | 0.00 | 0.00 | |
76 | Anti-Cancer Drug Design | journal | 0.910 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
77 | Clin-Alert | journal | 0.100 Q4 | 0 | 0 | 47 | 0 | 0 | 47 | 0.00 | 0.00 | 0.00 | |
78 | Molecular Therapy | journal | 209 | 170 | 0 | 5838 | 0 | 0 | 0.00 | 34.34 | 28.47 | ||
79 | National Toxicology Program technical report series | journal | 22 | 1 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®